ONC Q4 2020 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q4 2020 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$100M+75.9% YoY

Gross Profit

$79M78.9% margin

Operating Income

-$485M-484.4% margin

Net Income

-$473M-472.3% margin

EPS (Diluted)

$-5.20

QoQ Revenue Growth

+9.9%

Cash Flow

Operating Cash Flow

-$332M

Free Cash Flow

-$389M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$5.6B

Total Liabilities

$1.7B

Stockholders' Equity

$3.9B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$100M	$57M	+75.9%
Gross Profit	$79M	$39M	+103.1%
Operating Income	-$485M	-$388M	-25.0%
Net Income	-$473M	-$388M	-21.8%